Seaport Therapeutics Prices Upsized Initial Public Offering
MT Newswires Live
May 01
Seaport Therapeutics (SPTX) said Thursday it priced an upsized initial public offering of 14.2 million common shares at $18 each.
The transaction is priced at the top of the targeted range and is projected to generate $254.9 million in gross proceeds, the company said.
Underwriters hold a 30-day option to acquire up to 2.12 million additional shares at the public offering price, it said.
The stock is scheduled to debut on the Nasdaq Global Select Market on Friday under the SPTX ticker, with the offering expected to close Monday, Seaport Therapeutics said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.